Hidetaka Kamimura

1.9k total citations
98 papers, 1.6k citations indexed

About

Hidetaka Kamimura is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Hidetaka Kamimura has authored 98 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pharmacology, 41 papers in Oncology and 28 papers in Molecular Biology. Recurrent topics in Hidetaka Kamimura's work include Pharmacogenetics and Drug Metabolism (40 papers), Drug Transport and Resistance Mechanisms (39 papers) and Drug-Induced Hepatotoxicity and Protection (17 papers). Hidetaka Kamimura is often cited by papers focused on Pharmacogenetics and Drug Metabolism (40 papers), Drug Transport and Resistance Mechanisms (39 papers) and Drug-Induced Hepatotoxicity and Protection (17 papers). Hidetaka Kamimura collaborates with scholars based in Japan, United States and United Kingdom. Hidetaka Kamimura's co-authors include Takashi Usui, Yuji Mano, Kenichi Umehara, K. Noguchi, Saburo Higuchi, Takeshi Iwatsubo, Tsuyoshi Minematsu, Hiroshi Matsushima, Yoshiteru Kamiyama and Yasushi Yamazoe and has published in prestigious journals such as Scientific Reports, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Hidetaka Kamimura

95 papers receiving 1.5k citations

Peers

Hidetaka Kamimura

ONCOL

PHARM

PPCH

PHARM

Takafumi Iwatsubo Japan

Katherine S. Fenner United Kingdom

Oxana Doroshyenko Germany

Sheryl G. Wood United States

Brian Ethell United Kingdom

A. David Rodrigues United States

Hitoshi Ishizuka Japan

Philip Wastall United States

Tomomi Sugiyama Japan

Kumiko Noda Japan

Takafumi Iwatsubo Japan

Hidetaka Kamimura

524 ×0.8

ONCOL

688 ×1.1

PHARM

264 ×0.6

140 ×0.5

PPCH

155 ×0.7

PHARM

Citations per year, relative to Hidetaka Kamimura Hidetaka Kamimura (= 1×) peers Takafumi Iwatsubo

Countries citing papers authored by Hidetaka Kamimura

Since Specialization

Citations

This map shows the geographic impact of Hidetaka Kamimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetaka Kamimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetaka Kamimura more than expected).

Fields of papers citing papers by Hidetaka Kamimura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidetaka Kamimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetaka Kamimura. The network helps show where Hidetaka Kamimura may publish in the future.

Co-authorship network of co-authors of Hidetaka Kamimura

This figure shows the co-authorship network connecting the top 25 collaborators of Hidetaka Kamimura. A scholar is included among the top collaborators of Hidetaka Kamimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetaka Kamimura. Hidetaka Kamimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kamimura, Hidetaka, et al.. (2020). Predicted values for human total clearance of a variety of typical compounds with differently humanized-liver mouse plasma data. Drug Metabolism and Pharmacokinetics. 35(4). 389–396. 5 indexed citations

Kamimura, Hidetaka, Satoshi Ito, Kohei Nozawa, et al.. (2014). Formation of the Accumulative Human Metabolite and Human-Specific Glutathione Conjugate of Diclofenac in TK-NOG Chimeric Mice with Humanized Livers. Drug Metabolism and Disposition. 43(3). 309–316. 26 indexed citations

TERAMURA, Yoshinori, et al.. (2008). Pharmacokinetics and Tissue Distribution of Tacrolimus (FK506) After a Single or Repeated Ocular Instillation in Rabbits. Journal of Ocular Pharmacology and Therapeutics. 24(3). 309–319. 31 indexed citations

TERAMURA, Yoshinori, et al.. (2008). Absorption, Distribution, and Excretion of 14C-labeled Tacrolimus (FK506) after a Single or Repeated Ocular Instillation in Rabbits. Journal of Ocular Pharmacology and Therapeutics. 24(3). 333–343. 12 indexed citations

Umehara, Kenichi, et al.. (2008). Tissue distribution of YM758, a novel If channel inhibitor, in pregnant and lactating rats. Xenobiotica. 38(10). 1274–1288.

Minematsu, Tsuyoshi, Kenji Sugimoto, Nobuaki Shirai, et al.. (2008). Carrier-Mediated Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d ]imidazolium Bromide (YM155 Monobromide), a Novel Small-Molecule Survivin Suppressant, into Human Solid Tumor and Lymphoma Cells. Drug Metabolism and Disposition. 37(3). 619–628. 27 indexed citations

Umehara, Kenichi, et al.. (2008). Comparative evaluation of absorption, distribution, and excretion of YM758, a novel If channel inhibitor, between albino and non-albino rats. Xenobiotica. 38(5). 527–539. 8 indexed citations

Minematsu, Tsuyoshi, et al.. (2008). Role of Organic Anion Transporters in the Pharmacokinetics of Zonampanel, an α-Amino-3-hydroxy-5-methylisoxazole-4-propionate Receptor Antagonist, in Rats. Drug Metabolism and Disposition. 36(8). 1496–1504. 14 indexed citations

Kamiyama, Yoshiteru, Tsutomu Matsubara, Kouichi Yoshinari, et al.. (2007). Role of Human Hepatocyte Nuclear Factor 4α in the Expression of Drug-Metabolizing Enzymes and Transporters in Human Hepatocytes Assessed by Use of Small Interfering RNA. Drug Metabolism and Pharmacokinetics. 22(4). 287–298. 116 indexed citations

10.

Iwatsubo, Takafumi, et al.. (2007). Determination of solifenacin succinate, a novel muscarinic receptor antagonist, and its major metabolite in rat plasma by semi-micro high performance liquid chromatography. Journal of Chromatography B. 859(2). 241–245. 24 indexed citations

11.

Mano, Yuji, Takashi Usui, & Hidetaka Kamimura. (2007). Species Differences in Inhibition Potential of Nonsteroidal Anti-Inflammatory Drugs Against Estradiol 3β-Glucuronidation Between Rats, Dogs, and Humans. Journal of Pharmaceutical Sciences. 97(7). 2805–2810. 13 indexed citations

12.

Umehara, Kenichi, Takeshi Iwatsubo, K. Noguchi, & Hidetaka Kamimura. (2007). Comparison of the kinetic characteristics of inhibitory effects exerted by biguanides and H₂-blockers on human and rat organic cation transporter-mediated transport: Insight into the development of drug candidates. Xenobiotica. 37(6). 618–634. 34 indexed citations

13.

Kamimura, Hidetaka. (2006). Genetic polymorphism of cytochrome P450s in beagles: possible influence of CYP1A2 deficiency on toxicological evaluations. Archives of Toxicology. 80(11). 732–738. 23 indexed citations

14.

Mano, Yuji, Takashi Usui, & Hidetaka Kamimura. (2006). Identification of Human UDP-Glucuronosyltransferase Responsible for the Glucuronidation of Niflumic Acid in Human Liver. Pharmaceutical Research. 23(7). 1502–1508. 16 indexed citations

15.

Mano, Yuji, Takashi Usui, & Hidetaka Kamimura. (2004). In Vitro inhibitory effects of non‐steroidal antiinflammatory drugs on UDP‐glucuronosyltransferase 1A1‐catalysed estradiol 3β‐glucuronidation in human liver microsomes. Biopharmaceutics & Drug Disposition. 26(1). 35–39. 21 indexed citations

16.

Miyazawa, Yuri, et al.. (2002). Effects of the concomitant administration of tamsulosin (0.8 mg) on the pharmacokinetic and safety profile of intravenous digoxin (LanoxinR) in normal healthy subjects: a placebo-controlled evaluation. Journal of Clinical Pharmacy and Therapeutics. 27(1). 13–19. 5 indexed citations

17.

Kamimura, Hidetaka, Hiroshi Matsushima, Toyohiko Watanabe, et al.. (1998). Identification of cytochrome P450 isozymes involved in metabolism of theα₁-adrenoceptor blocker tamsulosin in human liver microsomes. Xenobiotica. 28(10). 909–922. 41 indexed citations

18.

Koiso, Kenkichi, Hideyuki Akaza, Koji Kikuchi, et al.. (1996). Pharmacokinetics of Tamsulosin Hydrochloride in Patients with Renal Impairment: Effects of α₁‐Acid Glycoprotein. The Journal of Clinical Pharmacology. 36(11). 1029–1038. 20 indexed citations

19.

Kamimura, Hidetaka, et al.. (1989). α-GLUCOSIDE FORMATION in vitro. Journal of Pharmacobio-Dynamics. 12(3). 2 indexed citations

20.

Kamimura, Hidetaka, et al.. (1988). Metabolic fate of indeloxazine hydrochloride: α-glucoside formation in rats. Xenobiotica. 18(2). 141–149. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact